三诺生物
(300298)
| 流通市值：101.59亿 | | | 总市值：125.89亿 |
| 流通股本：4.55亿 | | | 总股本：5.64亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 795,422,346.7 | 675,706,026.01 | 672,599,247.55 | 786,037,973.76 |
| 应收票据及应收账款 | 527,201,805.17 | 614,092,644.67 | 547,319,298.2 | 478,219,714.39 |
| 应收账款 | 527,201,805.17 | 614,092,644.67 | 547,319,298.2 | 478,219,714.39 |
| 应收款项融资 | 12,988,045.94 | 8,630,966.48 | 9,545,635.22 | 24,482,776.19 |
| 预付款项 | 60,873,362.4 | 47,616,870.69 | 76,448,776.96 | 47,076,662.94 |
| 其他应收款合计 | 39,548,497.06 | 44,245,018.93 | 18,517,075.81 | 13,086,701.13 |
| 存货 | 681,094,723.03 | 670,143,819.66 | 622,682,669.46 | 632,445,438.98 |
| 其他流动资产 | 43,927,439.07 | 42,409,875.27 | 51,345,411.7 | 47,491,524.13 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,211,056,219.37 | 2,102,845,221.71 | 1,998,458,114.9 | 2,106,340,791.52 |
| 非流动资产: | | | | |
| 长期应收款 | 834,832.57 | 922,910.9 | 1,010,087.94 | - |
| 长期股权投资 | 46,983,808.98 | 47,878,467.03 | 47,541,893.62 | 47,802,082.93 |
| 其他权益工具投资 | 298,455,130.32 | 310,885,012 | 328,970,213.8 | 328,482,846.44 |
| 固定资产 | 1,643,902,735.86 | 1,655,458,350.95 | 1,668,721,448.48 | 1,692,965,462.21 |
| 在建工程 | 180,160,186.03 | 173,369,491.96 | 141,003,808.02 | 107,435,286.65 |
| 使用权资产 | 21,452,895.78 | 25,568,232.03 | 28,823,530.45 | 28,427,059.47 |
| 无形资产 | 264,541,000.62 | 273,337,307.09 | 282,610,099.12 | 291,062,807.91 |
| 商誉 | 1,112,603,894.97 | 1,124,610,788.83 | 1,121,412,972.88 | 1,120,176,081.8 |
| 长期待摊费用 | 16,232,588.24 | 17,839,934.01 | 23,017,880.52 | 20,748,386.87 |
| 递延所得税资产 | 107,187,053.47 | 103,634,578.25 | 106,056,211.66 | 111,524,097.2 |
| 其他非流动资产 | 30,028,718.66 | 39,987,719.02 | 72,091,121.45 | 72,006,914.35 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,722,382,845.5 | 3,773,492,792.07 | 3,821,259,267.94 | 3,820,631,025.83 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,933,439,064.87 | 5,876,338,013.78 | 5,819,717,382.84 | 5,926,971,817.35 |
| 流动负债: | | | | |
| 短期借款 | 69,544,556.74 | 73,763.38 | 25,075,466.32 | 89,880,671.68 |
| 应付票据及应付账款 | 265,252,396.61 | 306,185,293.51 | 265,421,238.89 | 305,024,763.39 |
| 其中：应付票据 | 4,449,034.32 | 7,998,117.66 | 12,558,117.66 | 18,194,625 |
| 应付账款 | 260,803,362.29 | 298,187,175.85 | 252,863,121.23 | 286,830,138.39 |
| 预收款项 | - | - | 10,070.08 | - |
| 合同负债 | 433,792,257.94 | 461,147,281.08 | 430,462,768.81 | 435,809,098.37 |
| 应付职工薪酬 | 196,386,597.41 | 172,420,752.69 | 162,876,049.51 | 194,943,349.05 |
| 应交税费 | 46,101,787.41 | 42,360,633.24 | 59,956,835.46 | 43,541,937.83 |
| 其他应付款合计 | 134,630,810.18 | 110,999,980.76 | 114,947,820.78 | 110,826,160.69 |
| 其中:应付利息 | -30,050 | - | 34,895.83 | - |
| 一年内到期的非流动负债 | 390,762,317.97 | 393,058,913.5 | 92,615,457.96 | 95,577,477.82 |
| 其他流动负债 | 24,618,877.47 | 25,186,539.69 | 22,467,852.89 | 23,520,372.78 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,561,089,601.73 | 1,511,433,157.85 | 1,173,833,560.7 | 1,299,123,831.61 |
| 非流动负债: | | | | |
| 长期借款 | 65,312,625 | 98,212,625 | 409,750,000 | 438,202,375 |
| 应付债券 | 456,190,744.12 | 448,868,832.59 | 441,625,999.82 | 434,384,269.7 |
| 租赁负债 | 17,396,824.62 | 20,000,324.28 | 22,946,519.19 | 19,806,108.39 |
| 长期应付职工薪酬 | 1,353,153.82 | 1,353,580.94 | 1,388,753.87 | 1,460,412.09 |
| 预计负债 | 95,416,327.02 | 97,827,423.66 | 99,975,249.76 | 97,546,321.09 |
| 递延收益 | 117,864,805.89 | 120,185,270.54 | 122,139,795.29 | 124,094,398.78 |
| 递延所得税负债 | 43,612,300.23 | 38,955,807.76 | 36,228,178.72 | 41,633,831.67 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 797,146,780.7 | 825,403,864.77 | 1,134,054,496.65 | 1,157,127,716.72 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,358,236,382.43 | 2,336,837,022.62 | 2,307,888,057.35 | 2,456,251,548.33 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 564,265,375 | 564,265,375 | 564,265,373 | 564,265,373 |
| 其他权益工具 | 123,953,405.74 | 123,953,405.74 | 123,953,430.61 | 123,953,430.61 |
| 资本公积 | 1,094,754,850.02 | 1,090,307,434.07 | 1,086,761,848.92 | 1,087,027,813.78 |
| 减:库存股 | 253,582,392.93 | 253,582,392.93 | 253,582,392.93 | 202,777,079.4 |
| 其他综合收益 | 108,851,770.12 | 136,594,643.18 | 122,926,130.6 | 155,203,740.66 |
| 盈余公积 | 437,766,994.19 | 437,305,484.27 | 436,167,989.27 | 430,853,505.74 |
| 未分配利润 | 1,100,794,523.6 | 1,043,399,315.01 | 1,031,174,581.27 | 920,121,591.9 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,176,804,525.74 | 3,142,243,264.34 | 3,111,666,960.74 | 3,078,648,376.29 |
| 少数股东权益 | 398,398,156.7 | 397,257,726.82 | 400,162,364.75 | 392,071,892.73 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,575,202,682.44 | 3,539,500,991.16 | 3,511,829,325.49 | 3,470,720,269.02 |
| 负债和股东权益合计 | 5,933,439,064.87 | 5,876,338,013.78 | 5,819,717,382.84 | 5,926,971,817.35 |
| 公告日期 | 2024-10-24 | 2024-08-29 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |